Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2026 AL 2040

Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia

Sitek EJ, Sołtan W, Wieczorek D, Schinwelski M, Robowski P, Reilmann R, Guzińska K, Harciarek M, Krysa W, Sławek J.

J Int Neuropsychol Soc. 2011 Sep;17(5):788-95. doi: 10.1017/S1355617711000725. Epub 2011 Jun 8.

The excitatory neurotransmitter glutamate stimulates DNA repair to increase neuronal resiliency

Yang JL, Sykora P, Wilson DM 3rd, Mattson MP, Bohr VA.

Mech Ageing Dev. 2011 Aug;132(8-9):405-11. doi: 10.1016/j.mad.2011.06.005. Epub 2011 Jun 25.

An estimate of the global reduction in mortality rates through doubling vitamin D levels

Grant WB.

Eur J Clin Nutr. 2011 Sep;65(9):1016-26. doi: 10.1038/ejcn.2011.68. Epub 2011 Jul 6.

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson's disease

Yokoyama H, Kuroiwa H, Kasahara J, Araki T.

Acta Neurobiol Exp (Wars). 2011;71(2):269-80. doi: 10.55782/ane-2011-1847.

Cabergoline-induced tricuspid regurgitation: Case report and review of literature

Bhat MH, Mushtaq S, Saba S, Saif R, Ali G.

Indian J Endocrinol Metab. 2011 Apr;15(2):137-9. doi: 10.4103/2230-8210.81949.

Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia?

Lim SL, Teo SG, Kireyev D, Poh KK.

Singapore Med J. 2011 Jun;52(6):394-8; quiz 399.

Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease

Witt K, Daniels C, Krack P, Volkmann J, Pinsker MO, Kloss M, Tronnier V, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G.

J Neurol Sci. 2011 Nov 15;310(1-2):261-6. doi: 10.1016/j.jns.2011.06.028. Epub 2011 Jul 5.

Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: an incidental finding?

De Rosa A, Rinaldi C, Tucci T, Pappatà S, Rossi F, Morra VB, Faggiano A, Colao A, De Michele G.

Parkinsonism Relat Disord. 2011 Dec;17(10):771-3. doi: 10.1016/j.parkreldis.2011.04.021. Epub 2011 Jul 5.

Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy

Kurtis MM, Franch O.

Parkinsonism Relat Disord. 2011 Dec;17(10):774-6. doi: 10.1016/j.parkreldis.2011.05.024. Epub 2011 Jul 5.

A case of parkinsonism and dopa-induced severe dyskinesia associated with novel mutation in the GTP cyclohydrolase I gene

Irie S, Kanazawa N, Ryoh M, Mochizuki H, Nomura Y, Segawa M.

Parkinsonism Relat Disord. 2011 Dec;17(10):769-70. doi: 10.1016/j.parkreldis.2011.06.008. Epub 2011 Jul 5.

[Biological consequences of oxidative stress induced by pesticides]

Grosicka-Maciąg E.

Postepy Hig Med Dosw (Online). 2011 Jun 17;65:357-66. doi: 10.5604/17322693.948816.

[Thiamine and its derivatives in the regulation of cell metabolism]

Tylicki A, Siemieniuk M.

Postepy Hig Med Dosw (Online). 2011 Jul 6;65:447-69. doi: 10.5604/17322693.951633.

The curious case of phenocopies in families with genetic Parkinson's disease

Klein C, Chuang R, Marras C, Lang AE.

Mov Disord. 2011 Aug 15;26(10):1793-802. doi: 10.1002/mds.23853. Epub 2011 Jul 6.

Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors

Letchworth SR, Whiteaker P.

Biochem Pharmacol. 2011 Oct 15;82(8):862-72. doi: 10.1016/j.bcp.2011.06.022. Epub 2011 Jun 28.

Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas

Martinkova J, Trejbalova L, Sasikova M, Benetin J, Valkovic P.

Clin Neuropharmacol. 2011 Sep-Oct;34(5):179-81. doi: 10.1097/WNF.0b013e3182281b2f.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias